Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan C Grant

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
JAMA Network Open|April 28, 2021
Informed Consent-We Can and Should Do BetterStefan C Grant
JAMA|May 22, 2014
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial designBoris Pasche, Stefan C Grant
Cancer Chemotherapy and Pharmacology|August 17, 2004
Phase I study of green tea extract in patients with advanced lung cancerScott A Laurie, Vincent A Miller, Stefan C Grant, et al.
Oncotarget|October 6, 2016
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironmentCara C Schafer, Yong Wang, Kenneth P Hough, et al.
Molecular Cancer|April 14, 2018
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1Liang Liu, Jimmy Ruiz, Stacey S O'Neill, et al.
Clinical Lung Cancer|January 10, 2020
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical PracticeLaurie E Steffen McLouth, Thomas W Lycan, Beverly J Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)Giuseppe Giaccone, Channa Debruyne, Enriqueta Felip, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2015
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC)Daniel J Allendorf, Rodolfo E Bordoni, Stefan C Grant, et al.
Cancer Research|October 3, 2013
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathwaysAnandi Sawant, Cara C Schafer, Tong Huan Jin, et al.
JCO Oncology Practice|February 4, 2021
Unmet Care Needs and Financial Hardship in Patients With Metastatic Non-Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical PracticeLaurie E McLouth, Chandylen L Nightingale, Beverly J Levine, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
JAMA Network Open|April 28, 2021
Informed Consent-We Can and Should Do BetterStefan C Grant
JAMA|May 22, 2014
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial designBoris Pasche, Stefan C Grant
Cancer Chemotherapy and Pharmacology|August 17, 2004
Phase I study of green tea extract in patients with advanced lung cancerScott A Laurie, Vincent A Miller, Stefan C Grant, et al.
Oncotarget|October 6, 2016
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironmentCara C Schafer, Yong Wang, Kenneth P Hough, et al.
Molecular Cancer|April 14, 2018
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1Liang Liu, Jimmy Ruiz, Stacey S O'Neill, et al.
Clinical Lung Cancer|January 10, 2020
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical PracticeLaurie E Steffen McLouth, Thomas W Lycan, Beverly J Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)Giuseppe Giaccone, Channa Debruyne, Enriqueta Felip, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2015
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC)Daniel J Allendorf, Rodolfo E Bordoni, Stefan C Grant, et al.
Cancer Research|October 3, 2013
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathwaysAnandi Sawant, Cara C Schafer, Tong Huan Jin, et al.
JCO Oncology Practice|February 4, 2021
Unmet Care Needs and Financial Hardship in Patients With Metastatic Non-Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical PracticeLaurie E McLouth, Chandylen L Nightingale, Beverly J Levine, et al.
Pageof 2